CA1273878A - Preparation de nicotine pour administration transdermique - Google Patents

Preparation de nicotine pour administration transdermique

Info

Publication number
CA1273878A
CA1273878A CA000556623A CA556623A CA1273878A CA 1273878 A CA1273878 A CA 1273878A CA 000556623 A CA000556623 A CA 000556623A CA 556623 A CA556623 A CA 556623A CA 1273878 A CA1273878 A CA 1273878A
Authority
CA
Canada
Prior art keywords
oil
nicotine
preparation according
preparation
tobacco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000556623A
Other languages
English (en)
Inventor
Richard Philip Moody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1273878A publication Critical patent/CA1273878A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000556623A 1987-01-15 1988-01-15 Preparation de nicotine pour administration transdermique Expired CA1273878A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US347187A 1987-01-15 1987-01-15
US003,471 1987-01-15

Publications (1)

Publication Number Publication Date
CA1273878A true CA1273878A (fr) 1990-09-11

Family

ID=21706026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000556623A Expired CA1273878A (fr) 1987-01-15 1988-01-15 Preparation de nicotine pour administration transdermique

Country Status (1)

Country Link
CA (1) CA1273878A (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019241A1 (fr) * 1991-05-07 1992-11-12 Dynagen, Inc. Systeme d'administration a liberation prolongee regulee utilise pour cesser de fumer
US5298257A (en) * 1987-05-01 1994-03-29 Elan Transdermal Limited Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
WO1995023597A1 (fr) * 1994-03-04 1995-09-08 Trans-Onycha Limited Systeme d'administration par voie generale d'un medicament consistant a appliquer celui-ci sur les ongles
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
JP2005504094A (ja) * 2001-09-27 2005-02-10 ファーマシア アクティエボラーグ 新規の配合物及びその使用
WO2007066150A2 (fr) * 2005-12-07 2007-06-14 Pharmakodex Ltd Administration de principes actifs par voie transdermique pour l'obtention d'un effet systemique

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298257A (en) * 1987-05-01 1994-03-29 Elan Transdermal Limited Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
WO1992019241A1 (fr) * 1991-05-07 1992-11-12 Dynagen, Inc. Systeme d'administration a liberation prolongee regulee utilise pour cesser de fumer
AU657973B2 (en) * 1991-05-07 1995-03-30 Dynagen, Inc. A controlled, sustained release delivery system for smoking cessation
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5662920A (en) * 1993-07-26 1997-09-02 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US6280761B1 (en) 1993-07-26 2001-08-28 Pharmacia Ab Nicotine lozenge
US5593684A (en) * 1993-08-04 1997-01-14 Pharmacia Ab Method and therapeutic system for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
WO1995023597A1 (fr) * 1994-03-04 1995-09-08 Trans-Onycha Limited Systeme d'administration par voie generale d'un medicament consistant a appliquer celui-ci sur les ongles
JP2005504094A (ja) * 2001-09-27 2005-02-10 ファーマシア アクティエボラーグ 新規の配合物及びその使用
JP2010006845A (ja) * 2001-09-27 2010-01-14 Mcneil Ab 新規の配合物及びその使用
WO2007066150A2 (fr) * 2005-12-07 2007-06-14 Pharmakodex Ltd Administration de principes actifs par voie transdermique pour l'obtention d'un effet systemique
WO2007066150A3 (fr) * 2005-12-07 2007-11-15 Pharmakodex Ltd Administration de principes actifs par voie transdermique pour l'obtention d'un effet systemique

Similar Documents

Publication Publication Date Title
AU691826B2 (en) Improved nicotine lozenge and therapeutic method for smoking cessation
US4702916A (en) Analgesic stick compositions
US4946853A (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
KR101564434B1 (ko) 피부투과가 개선된 외용제 조성물
EP2134319B1 (fr) Compositions comprenant un agent de refroidissement physiologique
JP2009542657A (ja) ゲルの形態でのロピニロール含有薬学的組成物、その使用
CA1273878A (fr) Preparation de nicotine pour administration transdermique
ES2137993T3 (es) La utilizacion de glicerina para moderar el aporte transdermico de medicamentos.
RS52387B (en) FORMOTEROL THE BEST PREPARATION
CA2116036A1 (fr) Dispositif d'administration transdermique de melatonine
CA2123109A1 (fr) Fomentation contenant du ketorolac
RU2457822C2 (ru) Жидкая композиция для введения никотина
DE69229318D1 (de) Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
US20030008005A1 (en) Sublingual administration of dihydroergotamine for the treatment of migraine
Monti et al. Enhancement of transdermal penetration of dapiprazole through hairless mouse skin
CN100431531C (zh) 包含vp/va共聚物和非水性载体的透皮喷雾药物组合物
EP0535237A1 (fr) Composition soulageant les irritations cutanees et preparation pour administration percutanee a usage externe contenant ladite composition
WO1996000071A1 (fr) Traitement du besoin de nicotine et/ou des symptomes de manque du fumeur au moyen d'une composition liquide contenant de la nicotine et de la cafeine ou de la xanthine, pour administration par voie nasale
JP2002087926A (ja) 透過促進用の皮膚外用剤
NO321899B1 (no) Anvendelse av en farmasoytisk tilberedning for fremstilling av en antimykotisk gel.
JP2003081812A (ja) エアゾール製剤
US20130184233A1 (en) Personal Lubricant Compositions
JPWO2020138403A1 (ja) 皮膚外用組成物及びエアゾール剤
EP0918521B1 (fr) Formulation pour le traitement et/ou la prophylaxie de la demence
KR100857509B1 (ko) 글루코사민을 포함하는 관절염 치료용 경피흡수제제

Legal Events

Date Code Title Description
MKLA Lapsed